Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J reorganizes QC functions

This article was originally published in The Tan Sheet

Executive Summary

A new company-wide framework will help "facilitate more effective coordination of Johnson & Johnson's quality, compliance and supply chain organizations," according to Corporate Communication VP Jeffrey Leebaw. The spokesman said in an e-mail that CEO William Weldon announced the plan internally the week of Aug. 15 and appointed Corporate VP Ajit Shetty to oversee the new framework. Chief quality officers also will be named for J&J's consumer, pharmaceutical and medical device businesses, Leebaw added. Recalls of OTCs made by J&J's McNeil Consumer Healthcare subsidiary have attracted FDA and congressional investigations and the firm has spent much of 2010 plotting remediation of its manufacturing shortcomings (1"The Tan Sheet" Aug. 9, 2010)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel